Literature DB >> 32851561

Standards of care for Kasabach-Merritt phenomenon in China.

Wei Yao1, Ke-Lei Li2, Zhong-Ping Qin3, Kai Li1, Jia-Wei Zheng4, Xin-Dong Fan5, Lin Ma6, De-Kai Zhou7, Xue-Jian Liu8, Li Wei6, Li Li6, Mao-Zhong Tai2, Jin-Hu Wang9, Yi Ji10, Lin Zhou11, Hai-Jin Huang12, Xiao-Yun Gao13, Zhi-Jian Huang14, Song Gu15, He-Ying Yang16.   

Abstract

Kasabach-Merritt phenomenon (KMP) is a rare disease that is characterized by severe thrombocytopenia and consumptive coagulation dysfunction caused by kaposiform hemangioendothelioma or tufted hemangioma. This condition primarily occurs in infants and young children, usually with acute onset and rapid progression. This review article introduced standardized recommendations for the pathogenesis, clinical manifestation, diagnostic methods and treatment process of KMP in China, which can be used as a reference for clinical practice.

Entities:  

Keywords:  Kaposiform hemangioendothelioma; Kasabach−Merritt phenomenon; Tufted hemangioma

Year:  2020        PMID： 32851561     DOI： 10.1007/s12519-020-00379-9

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  44 in total

1.  Kasabach-Merritt syndrome: identification of platelet trapping in a tufted angioma by immunohistochemistry technique using monoclonal antibody to CD61.

Authors:  S K Seo; J C Suh; G Y Na; I S Kim; K R Sohn
Journal:  Pediatr Dermatol       Date:  1999 Sep-Oct       Impact factor: 1.588

2.  Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.

Authors:  Pavel Uhrin; Jan Zaujec; Johannes M Breuss; Damla Olcaydu; Peter Chrenek; Hannes Stockinger; Elke Fuertbauer; Markus Moser; Paula Haiko; Reinhard Fässler; Kari Alitalo; Bernd R Binder; Dontscho Kerjaschki
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

3.  Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.

Authors:  Beth A Drolet; Cameron C Trenor; Leonardo R Brandão; Yvonne E Chiu; Robert H Chun; Roshni Dasgupta; Maria C Garzon; Adrienne M Hammill; Craig M Johnson; Brook Tlougan; Francine Blei; Michèle David; Ravindhra Elluru; Ilona J Frieden; Sheila F Friedlander; Ionela Iacobas; John N Jensen; David M King; Margaret T Lee; Stephen Nelson; Manish Patel; Elena Pope; Julie Powell; Marcia Seefeldt; Dawn H Siegel; Michael Kelly; Denise M Adams
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

Review 4.  Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.

Authors:  Vilmarie Rodriguez; Adrianna Lee; Patricia M Witman; Peter A Anderson
Journal:  J Pediatr Hematol Oncol       Date:  2009-07       Impact factor: 1.289

5.  Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.

Authors:  O Enjolras; M Wassef; E Mazoyer; I J Frieden; P N Rieu; L Drouet; A Taïeb; J F Stalder; J P Escande
Journal:  J Pediatr       Date:  1997-04       Impact factor: 4.406

6.  Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.

Authors:  Stacy E Croteau; Marilyn G Liang; Harry P Kozakewich; Ahmad I Alomari; Steven J Fishman; John B Mulliken; Cameron C Trenor
Journal:  J Pediatr       Date:  2012-08-04       Impact factor: 4.406

Review 7.  Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.

Authors:  Ciara O'Rafferty; Grainne M O'Regan; Alan D Irvine; Owen P Smith
Journal:  Br J Haematol       Date:  2015-06-30       Impact factor: 6.998

8.  Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma.

Authors:  M Sarkar; J B Mulliken; H P Kozakewich; R L Robertson; P E Burrows
Journal:  Plast Reconstr Surg       Date:  1997-11       Impact factor: 4.730

9.  Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis.

Authors:  L R Zukerberg; B J Nickoloff; S W Weiss
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

Review 10.  Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review.

Authors:  Marion Nadal; Bruno Giraudeau; Elsa Tavernier; Annie-Pierre Jonville-Bera; Gerárd Lorette; Annabel Maruani
Journal:  Acta Derm Venereol       Date:  2016-05       Impact factor: 4.437
View more
  6 in total

1.  Dynamic profiles of SARS-Cov-2 infection from five Chinese family clusters in the early stage of the COVID-19 pandemic.

Authors:  Xiang-Gen Kong; Jin Geng; Tao Zhang; Bin Wang; An-Zhao Wu; Di Xiao; Zhao-Hua Zhang; Cai-Feng Liu; Li Wang; Xue-Mei Jiang; Yu-Chen Fan
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

2.  A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis.

Authors:  Fatemeh Khatami; Mohammad Saatchi; Seyed Saeed Tamehri Zadeh; Zahra Sadat Aghamir; Alireza Namazi Shabestari; Leonardo Oliveira Reis; Seyed Mohammad Kazem Aghamir
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

Review 3.  Pregnant women and infants against the infection risk of COVID-19: a review of prenatal and postnatal symptoms, clinical diagnosis, adverse maternal and neonatal outcomes, and available treatments.

Authors:  Leila Khedmat; Pegah Mohaghegh; Maryam Veysizadeh; Azadeh Hosseinkhani; Sanaz Fayazi; Monirsadat Mirzadeh
Journal:  Arch Gynecol Obstet       Date:  2021-11-29       Impact factor: 2.493

4.  Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma.

Authors:  Liang Wang; Jing Li; Changhua Wu; Dan Song; Zhuang Liu; Yanli Niu; Jie Zhou; Lei Guo
Journal:  Front Pediatr       Date:  2022-08-05       Impact factor: 3.569

5.  Combination therapy for pediatric patients with Kasabach-Merritt phenomenon: A single-center retrospective study.

Authors:  Li Zhang; Lang Liu; Huanmin Luo; Wenbiao Xu; Huishan Chen; Muxia Yan; Yiqian Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

6.  Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants.

Authors:  Qianlong Liu; Na Xiong; Xinyuan Gong; Haochongyang Tong; Xuanfeng Tan; Xinkui Guo
Journal:  Exp Ther Med       Date:  2022-08-09       Impact factor: 2.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.